The Weight-Loss Pill Has Arrived: What Orforglipron (Foundayo) Means for Ireland

Orforglipron (Foundayo) is the first GLP-1 weight-loss pill โ€” no needle, approved in the US in 2026. What the ATTAIN-1 clinical trial shows, how the tablet compares to Ozempic and Wegovy, and when the weight-loss pill will reach Ireland. A pharmacist’s guide from Laois Pharmacy.

Continue ReadingThe Weight-Loss Pill Has Arrived: What Orforglipron (Foundayo) Means for Ireland

Retatrutide: The ‘Triple G’ Weight-Loss Injection Explained โ€” and When Ireland Might See It

Retatrutide has produced up to 25% weight loss in Phase 3 trials โ€” the strongest yet. What the TRIUMPH clinical trials actually show, how it compares to Ozempic and Mounjaro, and the honest timeline for when it will be available in Ireland. A pharmacist’s guide.

Continue ReadingRetatrutide: The ‘Triple G’ Weight-Loss Injection Explained โ€” and When Ireland Might See It